The short life and rapid death of a novel antihypertensive and antianginal agent

This publication has 6 references indexed in Scilit:

• Profound symptomatic bradycardia associated with combined mibefradil and B‐blocker therapy
  The Medical Journal of Australia, 1998
• Life-Threatening Interaction of Mibefradil and β-Blockers With Dihydropyridine Calcium Channel Blockers
  JAMA, 1998
• Safety of Mibefradil, a New Once-a-Day, Selective T-Type Calcium Channel Antagonist
  The American Journal of Cardiology, 1997
• The design of the mortality assessment in congestive heart failure trial (MACH-1, Mibefradil)
  Clinical Cardiology, 1997
• Calcium channel diversity in the cardiovascular system
  Journal of the American College of Cardiology, 1996
• Selective inhibition of T-type Ca2+ channels by Ro 40-5967.
  Circulation Research, 1994